Biotech Bets
Investing framework for biotech stocks
Identifying successful biotech stocks is incredibly difficult because of FDA regulations. We want to scratch our own itch and devise a framework for reproducible investment success.
We set up a typeform survey to understand readers backgrounds and what they might hope to see from us in the future. One particularly engaged reader suggested a way to collect user submissions
As a result, we built a typeform survey for readers to submit names of biotech companies and drugs in their pipeline for analysis.
We decided to create an analysis for Orphazyme, a biotech company that had its drug recently rejected by the FDA. Our first email received about a 66% open rate and we received valuable feedback from friends regarding our designs and parts of the analysis that were difficult to understand or need adjusting.
We decided there might be a group of individuals interested in reading about what we were doing and quickly set up a landing page (https://mailchi.mp/c76503127282/biotech-bets).
We decided to send the page around our university, to see if it would appeal to our classmates as we are all poor students.
We were engrossed by r/WSB during the initial hype of $GME and $AMC. After discussing our own investment theses for a large amount of time, we decided to put our domain knowledge to the test and create our own biotech investment frame works.
Thus, Biotech Bets was born.